Acacia Venture Partners

Acacia Venture Partners

Acacia Venture Partners was established in 1995 by R. Thomas Goodrich in San Francisco, structuring itself as a single-family office with a venture capital operating model. The firm emerged during the early wave of digital health investing, placing capital into medical device, healthcare IT, and life sciences companies at a time when dedicated health-tech venture platforms were rare. The firm makes direct venture and growth-stage investments, concentrating on medical devices, healthcare services, and enterprise software applied to clinical workflows. Acacia has historically built concentrated positions, often leading or co-leading rounds rather than assembling broad index-like portfolios. Confirmed portfolio companies have included Corazon Technologies, a developer of catheter-based coronary therapies, and A-Med Systems, a surgical device company acquired by Guidant in 2005 (per public record). Geographically, the firm focuses on North American opportunities, primarily in the San Francisco Bay Area and other US innovation hubs. Acacia operates as a lean vehicle, with Goodrich serving as Managing Partner and primary investment decision-maker since the firm's founding. The office has historically managed a limited number of active portfolio positions rather than maintaining a large team of junior investment professionals. Adjacent vehicles or philanthropic structures have not been publicly disclosed. In recent years, the firm has maintained a lower public profile than its venture-capital peers, with no verifiable fund closes or newly announced investments surfacing in the last 24 months. Structurally, Acacia functions as a single-family office executing direct venture investments rather than operating as a registered fund manager raising outside limited-partner commitments. This architecture allows for indefinite holding periods and a lack of pressure to deploy on fund-cycle timelines — a posture that distinguishes it from institutional venture firms that must return capital to investors within a fixed horizon.